Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978))

Christian Rolfo*, Andrés F. Cardona, Massimo Cristofanilli, Luis Paz-Ares, Juan Jose Diaz Mochon, Ignacio Duran, Luis E. Raez, Alessandro Russo, Jose A. Lorente, Umberto Malapelle, Ignacio Gil-Bazo, Eloisa Jantus-Lewintre, Patrick Pauwels, Tony Mok, María José Serrano

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Abstract

The authors wish to change the affiliation details of Eloisa Jantus-Lewintre as follows: 20Molecular Oncology Laboratory, General University Hospital of Valencia Research Foundation; Department of Biotechnology, Univeristat Politècnica de València; CIBERONC, Spain. The authors take sole responsibility for this notice and would like to apologize to readers and editors of CROH for any inconvenience that it may have caused in the publication process of the article.

Original languageEnglish (US)
Article number103058
JournalCritical Reviews in Oncology/Hematology
Volume154
DOIs
StatePublished - Oct 2020

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978))'. Together they form a unique fingerprint.

Cite this